Serum Biomarkers to Predict Risk of Testicular and Penile Cancer in AMORIS

ecancermedicalscience - United Kingdom
doi 10.3332/ecancer.2017.762
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ecancer Global Foundation

Related search

Thyroid Cancer Risk in the Swedish AMORIS Study: The Role of Inflammatory Biomarkers in Serum

Oncotarget
Oncology
2017English

Metabolic Serum Biomarkers for the Prediction of Cancer: A Follow-Up of the Studies Conducted in the Swedish AMORIS Study

ecancermedicalscience
Cancer ResearchOncology
2015English

A Computational Modeling Approach for Deriving Biomarkers to Predict Cancer Risk in Premalignant Disease

Cancer Prevention Research
MedicineCancer ResearchOncology
2016English

Biomarkers Needed to Predict Progestin Response in Endometrial Cancer

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2017English

Serum Inflammatory Markers in Relation to Prostate Cancer Severity and Death in the Swedish AMORIS Study

International Journal of Cancer
Cancer ResearchOncology
2018English

Usefulness and Limitations of a Serum Screening System to Predict the Risk of Gastric Cancer

Internal Medicine
Internal MedicineMedicine
2020English

Inorganic Phosphate and the Risk of Cancer in the Swedish AMORIS Study

BMC Cancer
Cancer ResearchOncologyGenetics
2013English

Insulin-Related Biomarkers to Predict the Risk of Metabolic Syndrome

International Journal of Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2013English

Glucose and Lipoprotein Biomarkers and Breast Cancer Severity Using Data From the Swedish AMORIS Cohort

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy